Grifols Future Growth
Future criteria checks 4/6
Grifols is forecast to grow earnings and revenue by 28.8% and 5.9% per annum respectively. EPS is expected to grow by 31.5% per annum. Return on equity is forecast to be 11.6% in 3 years.
Key information
28.8%
Earnings growth rate
31.5%
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | 5.9% |
Future return on equity | 11.6% |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,030 | 823 | 873 | 1,189 | 7 |
12/31/2025 | 7,640 | 722 | 687 | 1,058 | 13 |
12/31/2024 | 7,098 | 469 | 530 | 856 | 14 |
12/31/2023 | 6,592 | 59 | -87 | 208 | N/A |
9/30/2023 | 6,535 | 23 | -217 | 119 | N/A |
6/30/2023 | 6,479 | 8 | -505 | -146 | N/A |
3/31/2023 | 6,358 | 47 | -485 | -107 | N/A |
12/31/2022 | 6,064 | 208 | -386 | -11 | N/A |
9/30/2022 | 5,549 | 149 | -272 | 50 | N/A |
6/30/2022 | 5,207 | 66 | -36 | 289 | N/A |
3/31/2022 | 5,016 | 112 | 137 | 454 | N/A |
12/31/2021 | 4,933 | 189 | 282 | 597 | N/A |
9/30/2021 | 5,044 | 361 | 400 | 727 | N/A |
6/30/2021 | 5,199 | 667 | 597 | 909 | N/A |
3/31/2021 | 5,231 | 562 | 847 | 1,183 | N/A |
12/31/2020 | 5,340 | 619 | 748 | 1,110 | N/A |
9/30/2020 | 5,392 | 687 | 663 | 1,081 | N/A |
6/30/2020 | 5,353 | 557 | 551 | 964 | N/A |
3/31/2020 | 5,235 | 697 | 425 | 842 | N/A |
12/31/2019 | 5,099 | 625 | 157 | 569 | N/A |
9/30/2019 | 4,961 | 552 | 309 | 668 | N/A |
6/30/2019 | 4,790 | 565 | 275 | 634 | N/A |
3/31/2019 | 4,620 | 568 | 147 | 477 | N/A |
12/31/2018 | 4,487 | 597 | 430 | 737 | N/A |
9/30/2018 | 4,332 | 699 | 365 | 680 | N/A |
6/30/2018 | 4,246 | 704 | 405 | 712 | N/A |
3/31/2018 | 4,279 | 672 | 473 | 789 | N/A |
12/31/2017 | 4,318 | 663 | 519 | 842 | N/A |
9/30/2017 | 4,348 | 571 | N/A | 751 | N/A |
6/30/2017 | 4,291 | 559 | N/A | 765 | N/A |
3/31/2017 | 4,153 | 554 | N/A | 640 | N/A |
12/31/2016 | 4,050 | 545 | N/A | 553 | N/A |
9/30/2016 | 4,014 | 537 | N/A | 683 | N/A |
6/30/2016 | 3,986 | 535 | N/A | 652 | N/A |
3/31/2016 | 3,985 | 529 | N/A | 767 | N/A |
12/31/2015 | 3,935 | 532 | N/A | 743 | N/A |
9/30/2015 | 3,789 | 533 | N/A | 755 | N/A |
6/30/2015 | 3,645 | 507 | N/A | 836 | N/A |
3/31/2015 | 3,466 | 478 | N/A | 888 | N/A |
12/31/2014 | 3,355 | 470 | N/A | 979 | N/A |
9/30/2014 | 3,133 | 417 | N/A | 882 | N/A |
6/30/2014 | 2,972 | 388 | N/A | 712 | N/A |
3/31/2014 | 2,856 | 376 | N/A | 625 | N/A |
12/31/2013 | 2,742 | 346 | N/A | 592 | N/A |
9/30/2013 | 2,708 | 326 | N/A | 525 | N/A |
6/30/2013 | 2,685 | 306 | N/A | 573 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OZTA's forecast earnings growth (28.8% per year) is above the savings rate (0.6%).
Earnings vs Market: OZTA's earnings (28.8% per year) are forecast to grow faster than the German market (15.1% per year).
High Growth Earnings: OZTA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: OZTA's revenue (5.9% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: OZTA's revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OZTA's Return on Equity is forecast to be low in 3 years time (11.6%).